Anti-thrombogenic material and manufacturing method therefor

• US 20020018903A1
• Filed: 07/17/2001
• Published: 02/14/2002
• Est. Priority Date: 07/21/2000
• Status: Abandoned Application

• Current Assignee: Miwatech Incorporated
• Original Assignee: Miwatech Incorporated
• Inventors: Kokubo, Tadashi, Fujisawa, Akira, Monbin, Kim, Muramatsu, Kazuaki
• Application Number:
  US09/907,063
• Publication Number:
  US 20020018903A1
• Time in Patent Office: Days
• US Class Current: 428/469
• CPC Class Codes: A61L 33/027 Other specific inorganic materials not covered by A61L33/022 or A61L33/025
• CPC Class Codes: C23C 22/64 Treatment of refractory metals or alloys based thereon

Abstract

Purpose: The object of the present invention is to provide an anti-thrombogenic material and a manufacturing method therefor permitting to surely treat a blood contact surface of complex shapes, and moreover, permitting to suppress not only generation of fibrin induced by a blood coagulation factor such as fibrinogen on the blood contact surface but also both of the adhesion and activation of platelets.

Means for solving the Problems: A porous layer made of alkaline titanate and having an irregular pore structure is formed on the surface of a substrate of pure titanium or a titanium alloy by immersing the substrate of pure titanium or a titanium alloy in an alkaline solution.

Claims

1. An anti-thrombogenic material, comprising a porous layer, having an irregular pore structure, made of alkaline titanate on a surface of a substrate made of pure titanium or titanium alloy.

2. The anti-thrombogenic material as claimed in claim 1, coated with a calcium phosphate material on the surface of said porous layer.

3. The anti-thrombogenic material as claimed in claim 1, wherein an average pore size of said porous layer is not larger than 1 μ

m.

4. A manufacturing method of the anti-thrombogenic material as claimed in claim 4, characterized in that the porous layer, which is made of alkaline titanate and has the irregular pore structure, is formed on the surface of the substrate made of pure titanium or titanium alloy by immersing the substrate made of pure titanium or titanium alloy in alkaline solution.

5. The manufacturing method of the anti-thrombogenic material as claimed in claim 4, comprising the steps of heating said substrate at a temperature not higher than 882°

C. after immersing the substrate in said alkaline solution.

6. The manufacturing method of the anti-thrombogenic material as claimed in claim 4 or 5, characterized in precipitating on the surface of said porous layer a calcium phosphate material by further immersing the substrate in a pseudo body fluid, after immersing the substrate in said alkaline solution or after heating the substrate at a transition temperature of titanium or lower if heating.